Tetanus Prophylaxis in Burn Patients

Introduction to Tetanus Prophylaxis

Burns are considered tetanus-prone wounds and require tetanus prophylaxis based on the patient's vaccination history, with a tetanus toxoid-containing vaccine indicated if more than 5 years have passed since the last dose, as recommended by the Advisory Committee on Immunization Practices (ACIP) 1
The Centers for Disease Control and Prevention (CDC) guidelines classify tetanus-prone wounds, including burns, as those contaminated with dirt, feces, soil, or saliva, puncture wounds, avulsions, and wounds resulting from missiles, crushing, and frostbite 1

The patient's vaccination history should be determined, and if unknown or uncertain, the patient should be considered to have had no previous tetanus toxoid doses, according to the CDC guidelines 1
Proper wound cleaning and debridement are critical components of tetanus prevention, as recommended by the CDC 2

If the last tetanus toxoid-containing vaccine was <5 years ago, no tetanus toxoid or TIG is needed, but if ≥5 years ago, a tetanus toxoid-containing vaccine should be administered, as recommended by the ACIP 1
For patients with unknown or incomplete vaccination history, or for immunocompromised patients, both tetanus toxoid-containing vaccine and Tetanus Immune Globulin (TIG) should be administered, with a TIG dose of 250 units IM, as recommended by the CDC 1, 2
The type of tetanus toxoid-containing vaccine to be administered depends on the patient's age and previous vaccination history, with DTaP recommended for children <7 years, Td for persons 7-10 years, and Tdap preferred for persons ≥11 years who have not previously received Tdap, as recommended by the ACIP 1

Persons with HIV infection or severe immunodeficiency who have contaminated wounds, including burns, should receive TIG regardless of their history of tetanus immunizations, as recommended by the CDC 1
Persons with a history of an Arthus reaction following a previous dose of tetanus toxoid-containing vaccine should not receive a tetanus toxoid-containing vaccine until >10 years after the most recent dose, regardless of the wound condition, as recommended by the ACIP 1
When both TIG and tetanus toxoid are indicated, they should be administered using separate syringes at different anatomical sites, as recommended by the CDC 1

Delaying wound care can lead to tetanus, and proper cleaning and debridement are as important as immunization, as recommended by the CDC 2
Overuse of TIG should be avoided, and it should be reserved for patients with unknown/incomplete vaccination history or immunocompromised patients, as recommended by the ACIP 1
Neglecting follow-up can lead to incomplete vaccination, and patients should be ensured to complete their primary vaccination series if it was previously incomplete, as recommended by the CDC 1